Development of Patient Derived Xenografts (PDXs) and Analysis of Tyrosine Kinase Receptor Expression in Patients With Squamous Cell Head and Neck Cancer (HNSCC) to Study Resistance Mechanisms Induced by Standard Therapy

Clinical trial NCT07471009 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07471009
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Squamous Cell Tumors of the Head and Neck (HNSCC)

Start date: 2026-03-31
Primary completion: 2026-03-31
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.